Barriers to and facilitators of paediatric medical device innovation: a scoping review protocol

Lynn Kysh1, Grzegorz Zapotoczny2,3, Lisa Manzanete4

  • 1Innovation Studio, Children's Hospital of Los Angeles, Los Angeles, California, USA.

BMJ Open
|June 5, 2024
PubMed

Insights

This scoping review examines barriers and facilitators for pediatric medical device clinical research infrastructure. Findings will inform strategies to improve pediatric device development and address inequities.

Area of Science:

  • Medical Device Development
  • Clinical Research Infrastructure
  • Pediatric Health

Background:

  • Paediatric medical device development lags behind adult devices, leading to inequities and safety concerns.
  • Despite legislative efforts, a significant gap persists in paediatric medical device innovation.
  • Clinical trials are a known bottleneck, yet effective research infrastructure components remain unclear.

Purpose of the Study:

  • To conduct a scoping review to understand infrastructural barriers and facilitators for paediatric medical device clinical research.
  • To inform the Pediatric Device Consortia's (PDC) multimodal research strategy.
  • To identify key factors influencing the successful development and implementation of paediatric medical devices.

Main Methods:

  • Scoping review of health sciences literature from 2007-present.
  • Databases searched include Medline, Embase, Cochrane CENTRAL, Web of Science, and IEEE Xplore, supplemented by grey literature.
  • Studies focusing on paediatric populations (0-21 years) and medical devices (FDA classification) involving human research will be included. Screening and data extraction will be performed by two independent reviewers using Covidence and REDCap.

Main Results:

  • This section is to be filled upon study completion.

Conclusions:

  • This research will provide crucial insights into optimizing clinical research infrastructure for paediatric medical devices.
  • Findings are expected to guide future initiatives aimed at reducing the paediatric-device gap and improving patient outcomes.
  • Dissemination will occur through peer-reviewed publications, conference presentations, and professional networks.
Abstract

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Barriers to Effective Communication II01:21

Barriers to Effective Communication II

The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.6K
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.5K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
196